The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-1 isolates and the characterization of the human neutralizing antibody B cell response to HIV-1 infection are important goals that are central to the design of an effective antibody-based vaccine.
Pubmed ID: 20098712 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line HEK293T/17 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line U-118MG is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsThis monoclonal targets HIV-1 Envelope gp120 V3
View all literature mentionsThis monoclonal targets HIV-1 Envelope gp120 V3
View all literature mentionsThis monoclonal targets HIV-1 Envelope gp41 N-heptad repeat
View all literature mentionsThis monoclonal targets HIV-1 Envelope CD4 binding site
View all literature mentions